Studies on changes in serum butyrylcholinesterase activity of rivastigmine transdermal preparation in Alzheimer's type dementia patients and its effect on cognitive function, lipid / blood pressure / sugar metabolism
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2019
Price : $35 *
At a glance
- Drugs Rivastigmine (Primary) ; Donepezil
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- 29 Mar 2019 Status changed from active, no longer recruiting to completed.
- 14 Mar 2019 Planned End Date changed from 31 Dec 2019 to 31 Mar 2019.
- 14 Mar 2019 Status has been changed to active, no longer recruiting.